-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q4 2019 to Q2 2024.
- Champions Oncology, Inc. Depreciation, Depletion and Amortization for the quarter ending July 31, 2024 was $449K, a 0.9% increase year-over-year.
- Champions Oncology, Inc. Depreciation, Depletion and Amortization for the twelve months ending July 31, 2024 was $1.7M, a 15.5% decline year-over-year.
- Champions Oncology, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.7M, a 19% decline from 2022.
- Champions Oncology, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.1M, a 40% increase from 2021.
- Champions Oncology, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.5M, a 62.2% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)